Oppenheimer Reiterates Outperform Rating on Artivion Inc. (AORT)

February 5, 2026 6:19 AM EST Send to a Friend
Oppenheimer analyst Suraj Kalia reiterated an Outperform rating and $50.00 price target on Artivion Inc. (NYSE: AORT).The analyst comments "Endospan's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login